tiprankstipranks
VISEN Pharmaceuticals (HK:2561)
:2561
Hong Kong Market
2561
VISEN Pharmaceuticals
RESEARCH TOOLSreports

VISEN Pharmaceuticals (2561) Financial Statements

0 Followers

VISEN Pharmaceuticals Financial Overview

VISEN Pharmaceuticals's market cap is currently HK$2.85B. The company's EPS TTM is HK$; its P/E ratio is -12.37; VISEN Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue¥ 2.78M¥ -1.67M¥ -2.30M
Gross Profit¥ 2.78M¥ -1.67M¥ -2.30M
Operating Income¥ -174.18M¥ -138.83M¥ -358.29M
EBITDA¥ -177.62M¥ -242.26M¥ -280.95M
Net Income¥ -182.24M¥ -249.57M¥ -288.97M
Balance Sheet
Cash & Short-Term Investments¥ 203.59M¥ 347.78M¥ 626.46M
Total Assets¥ 293.82M¥ 443.80M¥ 741.27M
Total Debt¥ 2.36M¥ 3.65M¥ 6.00M
Net Debt¥ -201.23M¥ -344.13M¥ -620.46M
Total Liabilities¥ 52.55M¥ 52.92M¥ 88.67M
Stockholders' Equity¥ 241.28M¥ 390.88M¥ 652.61M
Cash Flow
Free Cash Flow¥ -140.97M¥ -271.83M¥ -248.31M
Operating Cash Flow¥ -140.86M¥ -271.31M¥ -246.55M
Investing Cash Flow¥ -117.00K¥ -520.00K¥ -1.77M
Financing Cash Flow¥ -3.09M¥ -6.95M¥ -7.95M
Currency in CNY

VISEN Pharmaceuticals Earnings and Revenue History

Income Statement >

VISEN Pharmaceuticals Debt to Assets

Balance Sheet >

VISEN Pharmaceuticals Cash Flow

Cash Flow >

VISEN Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >